Form 4 for CTSO Cytosorbents Corp
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-27 · accession 0001104659-23-027440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-01 | 2023-02-27 | CTSO | Sobel Alan D. | Dir | G - Gift | $0.00 | -2,000 | 0 | -100% | $0 |
| 2023-03-01 | 2023-02-27 | CTSO | Sobel Alan D. | Dir | G - Gift | $0.00 | +2,000 | 81.3K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | G | D | 2,000 | $0.00 | 0 | I | — | — | |
| 2 | Common | Common Stock | 2023-02-27 | G | A | 2,000 | $0.00 | 81,300 | D Bernard Sobel Revocable Trust | — | — | (F2) Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 12,000 shares of common stock owned directly by the reporting person. (F1) Reflects the transfer of shares to the reporting person from the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary. |